Skip to the answer

Fesoterodine Uses, Dosage, Side Effects and Interactions

Brand name
Toviaz

Toviaz was the first fesoterodine product the FDA approved, in October 2008. An FDA-approved generic with the same active ingredient is listed.

Fesoterodine is a bladder-calming medicine (an antimuscarinic) used to treat overactive bladder in adults and, in some products, neurogenic detrusor overactivity (bladder overactivity caused by a nerve problem) in children 6 and older.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About FesoterodineType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Fesoterodine in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Fesoterodine (Toviaz) is an antimuscarinic, a drug that blocks the nerve signals telling the bladder muscle to squeeze so it holds more. It is one of the standard medicines for overactive bladder in adults, and some products also treat neurogenic detrusor overactivity (bladder overactivity from a nerve problem) in children 6 and older who weigh over 25 kg. It has been on the U.S. market since about 2008, and FDA-approved generics are listed. Most people tolerate it reasonably well, and dry mouth is the side effect people notice most, followed by constipation. Stop it and get emergency help for any swelling of the face, lips, tongue, or throat (angioedema), which can appear after the first dose or days later.

Key Takeaways From the HelloPharmacist Team

  • Take it once a day with liquid, with or without food, and swallow the extended-release tablet whole without chewing, splitting, or crushing it.
  • Give it a few weeks before judging it, since bladder control usually improves gradually rather than overnight.
  • Call your prescriber if passing urine gets harder or the stream turns weak, since your bladder may not be emptying.
  • Skip driving until you know whether it makes you drowsy or dizzy, especially after starting or raising the dose.

How we write and review this content: our editorial policy

Fesoterodine by the Numbers

Strengths
2
in one form
Makers and packagers
12
Earliest FDA record
2008
Rank by Medicaid prescriptions
#785 of 1,682 drugs
More prescriptions than 53% of the 1,682 drugs we measure
24,735 prescriptions, Q1–Q4 2025

Patient Information Guide for Fesoterodine

What It’s Used For

Fesoterodine is used for bladder conditions across several products.

  • Overactive bladder (OAB) in adults, with urge urinary incontinence, urgency, and frequency. This applies to all supported fesoterodine fumarate extended-release tablet labels and to Toviaz.
  • Neurogenic detrusor overactivity (NDO) in children 6 and older weighing over 25 kg. This is listed for Toviaz and one fesoterodine fumarate film-coated extended-release tablet label, not for the other tablet label.

How It Works

Fesoterodine is a muscarinic receptor blocker. After you swallow it, the body quickly converts it to its active form, 5-hydroxymethyl tolterodine. Muscarinic receptors help make the bladder muscle contract. Blocking them in the bladder is believed to calm those contractions.

Drug Class

WHO drug family

  • Drugs for urinary frequency and incontinence
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)

None. The FDA’s index lists no class of any kind for Fesoterodine.

The main drug class the FDA gives it. It is the class named on the drug’s label.

What It Does in the Body

Physiologic effect (PE)

None listed for Fesoterodine in the FDA’s index.

From our Patient Information GuideFesoterodine is a muscarinic receptor blocker. After you swallow it, the body quickly converts it to its active form, 5-hydroxymethyl tolterodine. Muscarinic receptors help make the bladder muscle contract. Read How Fesoterodine Works

A change it makes in how the body works.

Drug Family

WHO ATC classification
  • Drugs for urinary frequency and incontinence

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification, from the U.S. National Library of Medicine’s RxClass. Reference only, not medical advice.

Dosage

Fesoterodine is an extended-release tablet taken by mouth once a day.

  • Swallow it whole with liquid. Do not chew, divide, or crush it.
  • Take it with or without food.
  • Your prescriber may start low and increase the dose based on response and tolerability. Kidney function, certain other medicines, and a child's weight can change the dose.

Follow your prescriber and the product label.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Overactive bladder

Adults Starting dose 4 mg once a day Highest dose 8 mg once a day
  • Based upon individual response and tolerability, increase to 8 mg once daily

What overactive bladder is: A sudden, hard-to-control urge to urinate, often with going more often than usual.

Adults taking strong CYP3A4 inhibitors Highest dose 4 mg once a day
  • Maximum recommended dosage 4 mg orally once daily

Good to know

Strong CYP3A4 inhibitors

Adults with kidney problems (CLcr 30 to 89 mL/min) Usual dose 8 mg once a day

Good to know

Estimated using Cockcroft-Gault formula

CrCl means creatinine clearance, a measure of how well the kidneys work.

Adults with kidney problems (CLcr 15 to 29 mL/min) Usual dose 4 mg once a day

Good to know

Estimated using Cockcroft-Gault formula

CrCl means creatinine clearance, a measure of how well the kidneys work.

People with kidney problems Usual dose 4 mg once a day

Good to know

Estimated using Cockcroft-Gault formula

Bladder control problems from a nerve condition (neurogenic detrusor overactivity)

Children 6 years and older weighing more than 25 kg and up to 35 kg Usual dose 4 mg once a day Highest dose 8 mg once a day
  • If needed, may be increased to 8 mg orally once daily
Children 6 years and older weighing more than 35 kg Starting dose 4 mg once a day Usual dose 8 mg once a day Highest dose 8 mg once a day
  • After one week, increase to 8 mg orally once daily
Children weighing more than 35 kg taking strong CYP3A4 inhibitors Highest dose 4 mg once a day
  • Maximum recommended dosage 4 mg orally once daily

Good to know

Strong CYP3A4 inhibitors

People with kidney problems and children and weighing greater than 25 kg and up to 35 kg with , eGFR 30 to 89 mL/min/1.73m Usual dose 4 mg once a day

eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.

People with kidney problems and children and weighing greater than 25 kg and up to 35 kg with , eGFR 15 to 29 mL/min/1.73m Use is Not Recommended

eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.

People on dialysis · 25 up Use is Not Recommended
Children weighing more than 35 kg with kidney problems (eGFR 30 to 89) Starting dose 4 mg once a day Usual dose 8 mg once a day
  • After one week, increase to 8 mg orally once daily

eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.

Children weighing more than 35 kg with kidney problems (eGFR 15 to 29) Usual dose 4 mg once a day

eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.

People on dialysis · Pediatric patients weighing greater than 35 kg with renal impairment, eGFR <15 mL/min/1.73m2 or requiring dialysis Use is Not Recommended

eGFR means estimated glomerular filtration rate, a measure of how well the kidneys work.

See the Full Dosing Instructions on DailyMed →

Side Effects

Most side effects are related to the drug's drying, anticholinergic effects.

Common side effects

  • Dry mouth (the most common)
  • Constipation
  • Indigestion or upset stomach
  • Nausea
  • Dry eyes
  • Urinary tract infection
  • Painful urination
  • Dry throat or cough
  • In children: diarrhea, stomach pain, headache, weight gain, and some vision effects such as blurred vision

When to get medical help

  • Swelling of the face, lips, tongue, or throat (angioedema) can be life-threatening. Get emergency help and stop the medicine.
  • Trouble passing urine or a weak or blocked urine stream.
  • Severe constipation or signs your stomach or gut is slowing down.
  • Eye pain or vision changes if you have narrow-angle glaucoma.
  • Marked sleepiness, dizziness, or headache, especially after starting or raising the dose.
  • Worsening muscle weakness if you have myasthenia gravis.
  • Fast heartbeat, palpitations, or chest pain.

Get urgent help for swelling of the face, lips, tongue, or throat, or if you cannot pass urine. Also report severe constipation or marked sleepiness.

Warnings and Precautions

  • Angioedema: swelling of the face, lips, tongue, or throat. It can be life-threatening and may happen after the first dose or later.
  • Urinary retention: not recommended with significant bladder outlet obstruction, and contraindicated with urinary retention.
  • Slowed gut: contraindicated with gastric retention and not recommended with severe constipation.
  • Narrow-angle glaucoma: contraindicated if uncontrolled. Use with caution if treated.
  • Drowsiness and dizziness: avoid driving until you know how it affects you.
  • Myasthenia gravis: may worsen symptoms.
  • Heart rate: it can raise heart rate, especially at higher doses and in children.

Interactions

Some medicines change fesoterodine levels or add to its side effects.

  • Other antimuscarinic drugs: can increase dry mouth, constipation, and urinary retention.
  • Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin): raise levels of the active form, so the dose is limited.
  • Rifampin: lowers levels of the active form, but no dose change is recommended.
  • Moderate CYP3A4 inhibitors, including grapefruit juice: no dose change needed.
  • Warfarin and combined birth control pills: no significant effect found.

Interactions Listed in the FDA-Approved Label

From the Fesoterodine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Other antimuscarinic drugs
    What happensCoadministration with other antimuscarinic agents that produce dry mouth, constipation, urinary retention and other anticholinergic effects may increase the frequency and/or severity of such effects; anticholinergics may alter absorption of some drugs.
  • Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin)
    What happensKetoconazole led to approximately a doubling of Cmax and AUC of the active metabolite 5-HMT.
    What to doDoses greater than 4 mg are not recommended in adults; in children, reduce to 4 mg once daily if over 35 kg, and not recommended for 25 kg up to 35 kg.
  • Moderate CYP3A4 inhibitors (erythromycin, fluconazole, diltiazem, verapamil, grapefruit juice)
    What happensNo clinically relevant effect on fesoterodine pharmacokinetics.
    What to doNo dosing adjustments are recommended.
  • Weak CYP3A4 inhibitors For example: cimetidine
    What happensEffect was not examined; not expected to exceed the effect of moderate inhibitors.
  • CYP3A4 inducers (rifampin, carbamazepine)
    What happensRifampin decreased Cmax and AUC of the active metabolite by approximately 70% and 75%.
    What to doNo dosing adjustments are recommended.
  • CYP2D6 inhibitors
    What happensNot tested clinically; in CYP2D6 poor metabolizers Cmax and AUC of the active metabolite are increased 1.7- and 2-fold.
    What to doNo dosing adjustments are recommended.
  • Drugs metabolized by cytochrome P450
    What happensAt therapeutic concentrations the active metabolite does not have the potential to inhibit or induce Cytochrome P450 enzyme systems.
  • Oral contraceptives (ethinyl estradiol and levonorgestrel)
    What happensNo clinically significant changes in plasma concentrations of the contraceptives.
  • What happensFesoterodine 8 mg once daily has no significant effect on the pharmacokinetics or anticoagulant activity (PT/INR) of warfarin 25 mg.
    What to doStandard therapeutic monitoring for warfarin should be continued.
  • Laboratory tests
    What happensInteractions with laboratory tests have not been studied.
Read the label’s full interactions text

7 DRUG INTERACTIONS 7.1 Antimuscarinic Drugs Coadministration of fesoterodine fumarate extended-release tablets with other antimuscarinic agents that produce dry mouth, constipation, urinary retention, and other anticholinergic pharmacological effects may increase the frequency and/or severity of such effects. Anticholinergic agents may potentially alter the absorption of some concomitantly administered drugs due to anticholinergic effects on gastrointestinal motility. 7.2 CYP3A4 Inhibitors Doses of fesoterodine fumarate extended-release tablets greater than 4 mg are not recommended in adult patients taking strong CYP3A4 inhibitors, such as ketoconazole, itraconazole, and clarithromycin. The fesoterodine fumarate extended-release tablets dose in pediatric patients taking strong CYP3A4 inhibitors is recommended to be reduced to 4 mg once daily in patients >35 kg and is not recommended in patients weighing greater than 25 kg and up to 35 kg. In a study in adults, coadministration of the strong CYP3A4 inhibitor ketoconazole with fesoterodine led to approximately a doubling of the maximum concentration (C max ) and area under the concentration versus time curve (AUC) of 5-hydroxymethyl tolterodine (5-HMT), the active metabolite of fesoterodine. Compared with CYP2D6 extensive metabolizers not taking ketoconazole, further increases in the exposure to 5-HMT were observed in subjects who were CYP2D6 poor metabolizers taking ketoconazole. There is no clinically relevant effect of moderate CYP3A4 inhibitors on the pharmacokinetics of fesoterodine. Following blockade of CYP3A4 by coadministration of the moderate CYP3A4 inhibitor fluconazole 200 mg twice a day for 2 days, the average (90% confidence interval) increase in C max and AUC of the active metabolite of fesoterodine was approximately 19% (11% to 28%) and 27% (18% to 36%) respectively.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Allergy to fesoterodine, its ingredients, or tolterodine
  • Urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma
  • Bladder outlet obstruction, severe constipation, or myasthenia gravis
  • Kidney impairment, which may need a dose change
  • Pregnancy: no human data, and animal studies showed fetal harm at high exposures
  • Breastfeeding: no information on milk transfer
  • Children: approved only for NDO at age 6 and older and over 25 kg
  • Adults 75 and older: more likely to have antimuscarinic side effects

Overdose

Too much fesoterodine can cause severe anticholinergic effects. Treatment is symptom-based and supportive, and ECG (heart rhythm) monitoring is recommended. Contact poison control or seek emergency care right away.

Half-Life and How Your Body Processes It

Fesoterodine is well absorbed and is quickly converted to its active form, which reaches peak levels in about 5 hours. Food has no clinically relevant effect. The liver breaks it down using CYP2D6 and CYP3A4, and the kidneys remove much of it. The effective half-life is about 7 hours after oral dosing. People who are CYP2D6 poor metabolizers have about twice the exposure.

Storage

Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) . Protect from moisture.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Fesoterodine

From the licensed clinical database we use, rolled up per supplement, most serious first.

200 supplements and herbal products have documented interactions with Fesoterodine in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 9Major
  • 150Moderate
  • 41Minor

See the other 192

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Fesoterodine: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Fesoterodine — the kind of thing our pharmacy team would talk through with you at the counter.

What is fesoterodine for?

It treats overactive bladder in adults, which means sudden urges to urinate, leaking with those urges, and going often. Some products, including Toviaz, are also approved for neurogenic detrusor overactivity in children 6 and older who weigh over 25 kg. Your pharmacist can confirm which applies to your product.

How do I take it?

Take one tablet by mouth once a day, with or without food. Swallow it whole with liquid. Don't chew, split, or crush it because it's an extended-release tablet. Follow the dose your prescriber chose for you.

What side effects should I expect?

Dry mouth is the most common, and constipation is next. Some people get indigestion, dry eyes, or a urinary tract infection. Call your doctor if side effects bother you or you have trouble passing urine or severe constipation.

When should I get emergency help?

Get help right away if your face, lips, tongue, or throat swells, because that's angioedema and it can block breathing. It can show up after the first dose or later. Stop the medicine and call emergency services.

Can I drive on it?

Be careful until you know how it affects you. It can cause sleepiness and dizziness, especially when you start or raise the dose. Avoid driving or operating heavy machinery until then.

Do other medicines matter?

Yes. Tell me about antifungals like ketoconazole or itraconazole, or the antibiotic clarithromycin, since they can raise fesoterodine levels and limit your dose. Other medicines with drying effects can make dry mouth and constipation worse. It doesn't significantly affect warfarin or combined birth control pills.

Is fesoterodine available over the counter?

No. Fesoterodine is a prescription medicine: every fesoterodine product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was fesoterodine first available?

The earliest FDA record we hold for fesoterodine is from 2008: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when fesoterodine was first used.

Who makes fesoterodine?

12 companies currently list fesoterodine products in the FDA's NDC Directory, including Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Amneal Pharmaceuticals LLC. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of fesoterodine?

Fesoterodine is the generic name. Its brand name is Toviaz. Generic versions are listed under the name fesoterodine.

What is the generic name of Toviaz?

The generic name of Toviaz is fesoterodine. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

Is there a generic version of fesoterodine?

Yes. FDA-approved generic versions of fesoterodine are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does fesoterodine come in?

Fesoterodine is listed in the FDA's National Drug Code Directory in these forms and strengths. Extended-release tablet (by mouth): 4 mg and 8 mg. A listing does not mean every pharmacy stocks every strength.

How much does fesoterodine cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.73 to $0.90 per generic extended-release tablet across 2 strengths and $9.26 to $9.29 per extended-release tablet of brand-name Toviaz across 2 strengths as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a fesoterodine shortage?

No. Fesoterodine is not on the FDA's drug shortage list as of Nov 22, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the fesoterodine prescribing information (package insert)?

The full FDA-approved prescribing information for fesoterodine, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Pfizer Laboratories Div Pfizer Inc's, revised Apr 7, 2026, and links to it on DailyMed.

Can you crush fesoterodine?

Some forms of fesoterodine are on our Do Not Crush list of tablets and capsules that should not be crushed or chewed: fesoterodine fumarate (tablet, extended release); Toviaz (tablet, extended release). An extended-release form releases the medicine over many hours, and crushing or chewing it can release the whole dose at once. A form that is not on the list may still come with its own instructions, so check the label and ask your pharmacist before you crush, split or open any medicine. Each listed form’s reason and instructions are on our Do Not Crush list.

Is fesoterodine gluten free?

No fesoterodine label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 24 fesoterodine products from 12 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's fesoterodine by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See fesoterodine inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Fesoterodine

Skip the scrolling. Ask in your own words and get an answer from Fesoterodine’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Fesoterodine’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Fesoterodine on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Fesoterodine Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Fesoterodine Forms and Strengths (How It Comes)

Fesoterodine comes in 1 dose form, the extended-release tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Fesoterodine inactive ingredients by manufacturer.

Extended-release tablet

By mouth
Brands Toviaz (the first brand, 2008)
How this form is used
What it may be used for
  • Fesoterodine Fumarate extended-release tablets treat overactive bladder in adults.
  • Toviaz treats overactive bladder in adults.
  • Toviaz also treats neurogenic detrusor overactivity in children 6 and older weighing over 25 kg.
  • One fesoterodine fumarate film-coated extended-release tablet label also lists neurogenic detrusor overactivity in children 6 and older weighing over 25 kg.
Important instructions
  • Fesoterodine fumarate film-coated extended-release tablets are taken by mouth once daily.
  • Swallow whole with liquid. Do not chew, divide, or crush.
  • Fesoterodine fumarate film-coated extended-release tablets can be taken with or without food.
  • Follow your prescriber and the product label for dosing.
Available strengths 2 strengths
24 FDA-listed product records ⓘ

Fesoterodine on the U.S. Market: Products, Makers and Brands

How Fesoterodine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

12 companies list 24 Fesoterodine product records with the FDA, mostly as extended-release tablet; the earliest marketing or approval year on record is 2008. The one brand name in the directory today is Toviaz; the rest are generics.

1
Dose forms ⓘ
12
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
24
FDA-listed product records ⓘ
2008
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Powder (7) · Unfinished tablet, extended release (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Alembic Pharmaceuticals Inc.8%
Alembic Pharmaceuticals Limited8%
Amneal Pharmaceuticals LLC8%
Ascend Laboratories, LLC8%
Aurobindo Pharma Limited8%
Camber Pharmaceuticals, Inc.8%
Other makers50%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Fesoterodine Is Used (Medicaid Data)

How many Fesoterodine prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

24,735
Medicaid prescriptions filled (Q1–Q4 2025)
$2.6M paid by Medicaid, before rebates

How commonly is Fesoterodine prescribed? Of the 1,682 medications we measure, Fesoterodine ranks #785 by Medicaid prescriptions — more than 53% of them.

Where Fesoterodine ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Fesoterodine product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 8 mg 24 hr extended release oral tablet is the most-dispensed Fesoterodine product — about 52% of these Medicaid prescriptions.

24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet Most dispensed

12,778 Medicaid prescriptions (Q1–Q4 2025) 52% of Fesoterodine prescriptions shown $1.4M paid by Medicaid, before rebates ≈ $106 per prescription, before rebates

8 of 34 listed NDCs had Medicaid claims. RxNorm 810077

24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet

11,957 Medicaid prescriptions (Q1–Q4 2025) 48% of Fesoterodine prescriptions shown $1.2M paid by Medicaid, before rebates ≈ $104 per prescription, before rebates

8 of 33 listed NDCs had Medicaid claims. RxNorm 810071

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 16 of the 67 listed Fesoterodine NDCs had Medicaid claims.

Compare Fesoterodine Products

A representative set of FDA-listed product records for Fesoterodine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 24 of 24 products — FDA National Drug Code Directory. See every product, package size and price: browse all 24 Fesoterodine NDCs →

Fesoterodine Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list 2 Fesoterodine recalls since July 2021. Both are still ongoing or began in the last six months. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Ongoing Class III Dec 16, 2025 · Alembic Pharmaceuticals Limited
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
  • Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals… Lots: Lot# 2405003360, Exp Date: Jan 31, 2026 FDA record D-0248-2026 →
Ongoing Class III Oct 10, 2025 · Alembic Pharmaceuticals Limited
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
  • Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceut… Lots: Lot # 2405006633, Exp Date: 03/31/2026 FDA record D-0156-2026 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Fesoterodine in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
1
Strengths
2
Forms in current FDA listings
1 of 1
In current FDA listings No current FDA listing
Ingredient (IN) Fesoterodine RxCUI 797195
  1. Dose form (SCDF) Extended Release Oral Tablet RxCUI 810070
    In current FDA listings
    Its 2 strengths (SCD)
    • 4 mg 24-hour, fumarate RxCUI 810071
    • 8 mg 24-hour, fumarate RxCUI 810077

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Fesoterodine Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Fesoterodine: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick the generic or the brand and a strength to see how its price has changed since Nov 2023.

Version
Strength

At this strength, Toviaz costs pharmacies $9.29 per tablet.

For the generic 4 mg extended-release tablet, pharmacies paid an average of $0.734 per tablet as of Nov 18, 2026, down 21% from $0.930 a year earlier. At this strength, Toviaz costs pharmacies $9.29 per tablet.

What pharmacies pay now
$0.734
per tablet, as of Nov 18, 2026
Last 4 weeks
Down 5.4%
from $0.777 on Oct 21, 2026
Last 12 months
Down 21%
from $0.930 on Nov 19, 2025
Lowest and highest since Nov 2023
$0.649 to $1.14
per tablet

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic 4 mg extended-release tablet: the average pharmacy price per tablet, the last survey of each month
MonthPharmacy price
Nov 2026$0.734
Oct 2026$0.777
Sep 2026$0.794
Aug 2026$0.791
Jul 2026$0.790
Jun 2026$0.833
May 2026$0.846
Apr 2026$0.840
Mar 2026$0.824
Feb 2026$0.841
Jan 2026$0.883
Dec 2025$0.909
Nov 2025$0.930
Oct 2025$0.901
Sep 2025$0.878
Aug 2025$0.893
Jul 2025$0.881
Jun 2025$0.882
May 2025$0.858
Apr 2025$0.864
Mar 2025$0.851
Feb 2025$0.830
Jan 2025$0.788
Dec 2024$0.814
Nov 2024$0.727
Oct 2024$0.918
Sep 2024$0.924
Aug 2024$0.929
Jul 2024$0.649
Jun 2024$0.875
May 2024$0.908
Apr 2024$0.959
Mar 2024$1.03
Feb 2024$1.05
Jan 2024$1.13
Dec 2023$1.14
Nov 2023$1.06
FormStrengthVersion What pharmacies pay
Extended-release tablet · Oral 4 mg Generic $0.734 per tablet NDC details & price history
Extended-release tablet · Oral 4 mg Toviaz (brand) $9.29 per tablet NDC details & price history
Extended-release tablet · Oral 8 mg Generic $0.897 per tablet NDC details & price history
Extended-release tablet · Oral 8 mg Toviaz (brand) $9.26 per tablet NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Fesoterodine Brand Names

Fesoterodine has one brand name on record: Toviaz. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Toviaz the first brand, 2008

Who Makes Fesoterodine: Manufacturers and Labelers

12 companies list Fesoterodine products with the FDA. By number of product records, the largest are Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Amneal Pharmaceuticals LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Alembic Pharmaceuticals Inc. 2 Alembic Pharmaceuticals Limited 2 Amneal Pharmaceuticals LLC 2 Ascend Laboratories, LLC 2 Aurobindo Pharma Limited 2 Camber Pharmaceuticals, Inc. 2 Dr.Reddy's Laboratories Inc., 2 Golden State Medical Supply, Inc. 2 NorthStar RxLLC 2 Pfizer Laboratories Div Pfizer Inc 2 Zydus Lifesciences Limited 2 Zydus Pharmaceuticals USA Inc. 2

Sources for This Fesoterodine Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Apr 7, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Fesoterodine.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 12 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
12
Finished products in the current FDA directory
24
Companies listing them (makers, repackagers, distributors)
12
FDA labeler codes behind them ⓘ
12
Linked representative label ⓘ
Pfizer Laboratories Div Pfizer Inc
Linked label effective
Apr 7, 2026
Composite sections available
23
Linked SPL Set ID
5be745f0-8ae7-4c3c-9962-37d6263326f1
Linked SPL Document ID
ca2031f1-5425-4d31-bf14-c865ec4e89b7
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Pfizer Laboratories Div Pfizer Inc is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →